Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE) with a KD of 0.393 nM. Omalizumab binds to the human FcgammaRIIb receptors with a KD of 6.37 uM. Omalizumab has the potential for persistent allergic asthma research[1][2]. The component ratio of this product is Active ingredient : Excipients = 1:1.3-1:1.5.
Molecular Weight:
(146.46 kDa)
Purity:
99.70
CAS Number:
[242138-07-4]
Target:
Interleukin Related
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
